Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Distinct genetic alterations and luminal molecular subtype in nested variant of urothelial carcinoma (NVUC).

Weyerer V, Weisser R, Moskalev EA, Haller F, Stoehr R, Eckstein M, Zinnall U, Gaisa NT, Compérat E, Perren A, Keck B, Allory Y, Kristiansen G, Wullich B, Agaimy A, Hartmann A, Bertz S.

Histopathology. 2019 Jul 26. doi: 10.1111/his.13958. [Epub ahead of print]

PMID:
31348552
2.

Distinguishing nested variants of urothelial carcinoma from benign mimickers by TERT promoter mutation.

Zhong M, Tian W, Zhuge J, Zheng X, Huang T, Cai D, Zhang D, Yang XJ, Argani P, Fallon JT, Epstein JI.

Am J Surg Pathol. 2015 Jan;39(1):127-31. doi: 10.1097/PAS.0000000000000305.

PMID:
25118812
3.

Micropapillary urothelial carcinoma: evaluation of HER2 status and immunohistochemical characterization of the molecular subtype.

Zinnall U, Weyerer V, Compérat E, Camparo P, Gaisa NT, Knuechel-Clarke R, Perren A, Lugli A, Toma M, Baretton G, Kristiansen G, Wirtz RM, Cheng L, Wullich B, Stoehr R, Hartmann A, Bertz S.

Hum Pathol. 2018 Oct;80:55-64. doi: 10.1016/j.humpath.2018.05.022. Epub 2018 Jun 6.

4.

Immunohistochemiocal subtyping using CK20 and CK5 can identify urothelial carcinomas of the upper urinary tract with a poor prognosis.

Sikic D, Keck B, Wach S, Taubert H, Wullich B, Goebell PJ, Kahlmeyer A, Olbert P, Isfort P, Nimphius W, Hartmann A, Giedl J; Bridge Consortium.

PLoS One. 2017 Jun 20;12(6):e0179602. doi: 10.1371/journal.pone.0179602. eCollection 2017.

5.

FOXA1 and CK14 as markers of luminal and basal subtypes in histologic variants of bladder cancer and their associated conventional urothelial carcinoma.

Warrick JI, Kaag M, Raman JD, Chan W, Tran T, Kunchala S, Shuman L, DeGraff D, Chen G.

Virchows Arch. 2017 Sep;471(3):337-345. doi: 10.1007/s00428-017-2190-3. Epub 2017 Jul 18.

PMID:
28721490
6.
7.

Nested variant of urothelial carcinoma of the urinary bladder.

Terada T.

Rare Tumors. 2011 Oct 21;3(4):e42. doi: 10.4081/rt.2011.e42. Epub 2011 Dec 27.

8.

Immunohistochemical evaluation of novel and traditional markers associated with urothelial differentiation in a spectrum of variants of urothelial carcinoma of the urinary bladder.

Paner GP, Annaiah C, Gulmann C, Rao P, Ro JY, Hansel DE, Shen SS, Lopez-Beltran A, Aron M, Luthringer DJ, De Peralta-Venturina M, Cho Y, Amin MB.

Hum Pathol. 2014 Jul;45(7):1473-82. doi: 10.1016/j.humpath.2014.02.024. Epub 2014 Mar 14.

PMID:
24780825
9.

Targeted DNA and RNA Sequencing of Paired Urothelial and Squamous Bladder Cancers Reveals Discordant Genomic and Transcriptomic Events and Unique Therapeutic Implications.

Hovelson DH, Udager AM, McDaniel AS, Grivas P, Palmbos P, Tamura S, Lazo de la Vega L, Palapattu G, Veeneman B, El-Sawy L, Sadis SE, Morgan TM, Montgomery JS, Weizer AZ, Day KC, Neamati N, Liebert M, Keller ET, Day ML, Mehra R, Tomlins SA.

Eur Urol. 2018 Dec;74(6):741-753. doi: 10.1016/j.eururo.2018.06.047. Epub 2018 Jul 20.

PMID:
30033047
10.

Clinicopathologic and Immunohistochemical Study of Combined Small Cell Carcinoma and Urothelial Carcinoma Molecular Subtype.

Xiao GQ, Barrett MM, Yang Q, Unger PD.

Pathol Oncol Res. 2019 Jul;25(3):889-895. doi: 10.1007/s12253-017-0369-1. Epub 2017 Dec 16.

PMID:
29249035
11.

Gene Expression Profile of the Clinically Aggressive Micropapillary Variant of Bladder Cancer.

Guo CC, Dadhania V, Zhang L, Majewski T, Bondaruk J, Sykulski M, Wronowska W, Gambin A, Wang Y, Zhang S, Fuentes-Mattei E, Kamat AM, Dinney C, Siefker-Radtke A, Choi W, Baggerly KA, McConkey D, Weinstein JN, Czerniak B.

Eur Urol. 2016 Oct;70(4):611-620. doi: 10.1016/j.eururo.2016.02.056. Epub 2016 Mar 15.

12.

Invasive urothelial carcinoma exhibiting basal cell immunohistochemical markers: A variant of urothelial carcinoma associated with aggressive features.

Mai KT, Truong LD, Ball CG, Williams P, Flood TA, Belanger EC.

Pathol Res Pract. 2015 Aug;211(8):610-8. doi: 10.1016/j.prp.2015.05.005. Epub 2015 May 27.

PMID:
26100813
13.

Next-generation sequencing-based molecular characterization of primary urinary bladder adenocarcinoma.

Roy S, Pradhan D, Ernst WL, Mercurio S, Najjar Y, Parikh R, Parwani AV, Pai RK, Dhir R, Nikiforova MN.

Mod Pathol. 2017 Aug;30(8):1133-1143. doi: 10.1038/modpathol.2017.33. Epub 2017 May 26.

14.

[Morphological and immunohistochemical characteristics of the molecular subtypes of urothelial carcinomas].

Osmanov YI, Gaibov ZA, Kogan EA, Radenska-Lopovok SG, Tursunov KZ.

Arkh Patol. 2019;81(5):35-44. doi: 10.17116/patol20198105135. Russian.

PMID:
31626203
15.

Prognostic stratification of muscle invasive urothelial carcinomas using limited immunohistochemical panel of Gata3 and cytokeratins 5/6, 14 and 20.

Jangir H, Nambirajan A, Seth A, Sahoo RK, Dinda AK, Nayak B, Kaushal S.

Ann Diagn Pathol. 2019 Aug 3;43:151397. doi: 10.1016/j.anndiagpath.2019.08.001. [Epub ahead of print]

PMID:
31494492
16.

Pelvic urothelial carcinoma with nested pattern of growth and an uncommon clinical presentation: a case report.

Tripodi S, Rocca BJ, Ambrosio MR, Gentile F, Cintorino M.

Anal Quant Cytol Histol. 2011 Dec;33(6):340-4.

PMID:
22590812
17.

Immunohistochemistry of cytokeratin (CK) 5/6, CD44 and CK20 as prognostic biomarkers of non-muscle-invasive papillary upper tract urothelial carcinoma.

Jung M, Kim B, Moon KC.

Histopathology. 2019 Feb;74(3):483-493. doi: 10.1111/his.13763. Epub 2018 Dec 2.

PMID:
30286252
18.

Predicting outcomes in non-muscle invasive (Ta/T1) bladder cancer: the role of molecular grade based on luminal/basal phenotype.

Rebola J, Aguiar P, Blanca A, Montironi R, Cimadamore A, Cheng L, Henriques V, Lobato-Faria P, Lopez-Beltran A.

Virchows Arch. 2019 Jun 25. doi: 10.1007/s00428-019-02593-x. [Epub ahead of print]

PMID:
31240474
19.

Nested variant of urothelial carcinoma of renal pelvis - a case report.

Kuzaka P, Pastewka K, Faryna J, Kuzaka B, Pypno W, Wejman J.

Pol J Pathol. 2014 Mar;65(1):74-7.

20.

Genomic Signature of Driver Genes Identified by Target Next-Generation Sequencing in Chinese Non-Small Cell Lung Cancer.

Wen S, Dai L, Wang L, Wang W, Wu D, Wang K, He Z, Wang A, Chen H, Zhang P, Dong X, Dong YA, Wang K, Yao M, Wang M.

Oncologist. 2019 Mar 22. pii: theoncologist.2018-0572. doi: 10.1634/theoncologist.2018-0572. [Epub ahead of print]

PMID:
30902917

Supplemental Content

Support Center